← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	76 Mesoblast MESO $1.81B	42	+1	+2%	$16.2M
77	77 Senti Biosciences Holdings SNTI $8.14M	42	+3	+8%	$175M
78	78 DELISTED NKGen Biotech, Inc. Common Stock NKGN	41	+4	+11%	$109M
79	DBTX 79 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	40	+4	+11%	$81.7M
80	80 Opus Genetics IRD $337M	40	+10	+33%	$8.07M
81	PTE 81 DELISTED PolarityTE, Inc. Common Stock PTE	39	-8	-17%	$5.83M
82	82 Imunon IMNN $5.95M	37	0	0%	$4.14M
83	83 DELISTED CERo Therapeutics CERO	36	+36	–	$104M
84	GRCL 84 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	35	+1	+3%	$203M
85	ONCS 85 DELISTED OncoSec Medical Incorporated ONCS	34	+3	+10%	$5.31M
86	86 DELISTED Scorpius Holdings, Inc. SCPX	33	+4	+14%	$8.87M
87	ACHL 87 DELISTED Achilles Therapeutics ACHL	30	+10	+50%	$137M
88	88 TScan Therapeutics TCRX $16.2M	29	+2	+7%	$44.4M
89	89 Calidi Biotherapeutics CLDI $2.25M	27	+27	–	$165M
90	90 DELISTED Orgenesis Inc. Common Stock ORGS	26	0	0%	$4.99M
91	91 PharmaCyte Biotech PMCB $3.84M	26	+4	+18%	$8.68M
92	92 Capricor Therapeutics CAPR $423M	25	-5	-17%	$6.8M
93	93 Genprex GNPX $1.88M	25	-3	-11%	$9.78M
94	BLCM 94 DELISTED Bellicum Pharmaceuticals, Inc. BLCM	24	-4	-14%	$2.19M
95	95 Celularity CELU $43.2M	24	+3	+14%	$85.6M
96	96 BioCardia BCDA $14.2M	23	+1	+5%	$5.78M
97	97 Enlivex Ltd ENLV $4.46M	23	+3	+15%	$4.12M
98	RCOR 98 DELISTED Renovacor, Inc. RCOR	23	+1	+5%	$58.4M
99	99 MiNK Therapeutics INKT $50.7M	21	+21	–	$5.96M
100	SCPS 100 DELISTED Scopus BioPharma Inc. Common Stock SCPS	21	+7	+50%	$4.71M